Avesthagen Wipro have launched genetic tests for cancer, neurological disorders, and rare diseases

Avesthagen is an India-based globally-focused biotechnology company with a corporate mission to utilize innovative science to develop new products and novel technologies for predictive, preventive, and personalized healthcare and food security through the convergence of food, pharmaceuticals, and population genetics.

Avesthagen Limited, a global leader in information technology, consulting, and business process outsourcing, has formed a four-year strategic partnership with Wipro Limited to commercialize its genetic testing portfolio. The genome panels in the portfolio provide highly specific, disease-centric analysis for cancer, neurodegenerative diseases, autoimmune disorders, and rare disease conditions.

Avesthagen and Wipro will collaborate on the project "Cancer Risk Assessed by NGS Profiling of Circulating free DNA and RNA for Lung Cancer Project Related Genomics Sequencing Services." The project will be co-led by Avesthagen and Wipro, with Wipro's cutting-edge Lifesciences lab performing initial sample processing, generating data on the latest Next-generation sequencing platforms, compiling genomic sequences, and analyzing detailed molecular information using computational AI/ML tools.

Wipro's expertise in genomics and biomarker discovery will assist Avesthagen in developing well-regulated workflows during the development of CALiBRx® gene panels.  The tests would primarily be available in oncology-focused super specialty clinics and hospitals. Later, it will strategically release diagnostic tools for upper respiratory cancers such as head, neck, and esophageal cancers. The project would result in a new generation of genome-led medicine in the medium and long term.

"Genomics-based innovation is in Avesthagen's DNA." The Avestagenome Project, which began in 2008, is the world's largest epidemiological study of a consanguineous population.  "The diagnostic tools portfolio that we are launching today is the result of the collective knowledge that we have amassed since, and we are excited to work with WIPRO to bring clinical genetics-based precision diagnostics to the people," says Dr. Villoo Morawala-Patell, Founder, Chairman, and Managing Director, Avesthagen Limited. 

The 624 gene panel CALiBRxO will be available in the market in Q3 2022 and will be used to treat cancers and neurological conditions. It presents a targeted screening approach of 624 genes implicated in oncological conditions. 

Tags : #avesthagen #wipro #Genetic #Cancer #neurological #rarediseases #featured #healthcare #medicircle #smitakumar

About the Author

Shweta Yadav

I strive to provide you with the most current and up-to-date healthcare news and articles in all main areas. Within the Medicircle umbrella, a wide range of themes and categories concerning health.

Related Stories

Loading Please wait...


Trending Now

Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023
Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023
Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy PartnershipDecember 06, 2023
Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
2nd IHub-Data Mobility Summit heldNovember 16, 2023